Skip to Content

Technologies | Biotech

We have grown-up hand in hand with biotech. We bring this wisdom and deep scientific expertise to bear on our client work – and it shows.

Our lawyers understand the unique business implications of high costs and long development times in the biotech industry. We know how to navigate all the nuances of taking a discovery to market. Universities, research institutions, startups, and investors alike value our strategic approach to maximize their market opportunity and protect their intellectual property against competitors.

Our clients benefit from our extensive experience in:
  • Molecular and cell biology
  • Developmental biology
  • Biochemistry
  • Genetics
  • Transgenic organisms
  • Neuroscience
  • Immunology
  • Drug delivery
  • Tissue engineering


Biotechnology IP Services

  • IP strategy development
  • IP audit and landscape analysis
  • Prosecuting and filing patent applications in the U.S. and foreign jurisdictions
  • Representation in patent interferences, reexamination proceedings, and international oppositions
  • Litigation support
  • Due diligence for mergers, acquisitions, and partnering
  • Drafting and negotiating license agreements
  • Trademark prosecution and counseling
Below are exemplary patents that we have obtained for our clients in the biotechnology industry:
 
  • US Patent no. 10,961,301 “Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair” assigned to Yale University, The Regents of the University of California, Department of Veterans Affairs
  • US Patent no. 10,953,105 “Immunostimulatory compositions and methods of use thereof” assigned to Massachusetts Institute of Technology
  • US Patent no. 10,940,171 “Microbial production of pure single stranded nucleic acids” assigned to Massachusetts Institute of Technology
  • US Patent no. 10,876,142 “Compositions and methods for making selenocysteine containing polypeptides” assigned to Yale University
  • US Patent no. 10,821,143 “Chimeric VSV virus compositions and methods of use thereof for treatment of cancer” assigned to Yale University
Technologies